Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Quality of Life Research
Gepubliceerd in:

06-06-2015

Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases

Auteurs: Phantipa Sakthong, Nontapat Sonsa-ardjit, Pattarin Sukarnjanaset, Wipaporn Munpan

Gepubliceerd in: Quality of Life Research | Uitgave 12/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Due to the problem of high ceiling effects of the EQ-5D-3L, the EQ-5D-5L was developed. However, little was known about the full psychometric properties of the EQ-5D-5L. Thus, this study aimed to evaluate its practicality, reliability, validity, and responsiveness in Thai patients with chronic diseases.

Methods

One thousand one hundred and fifty-six adults taking a medicine at least 3 months were identified from three university hospitals in Bangkok, Thailand, between July 2014 and March 2015. Practicality was evaluated by administration times and ceiling effects. Test–retest reliability was assessed using weighted kappa and intraclass correlation coefficients (ICCs). Validity was tested with correlations between the EQ-5D-5L and WHOQoL-BREF and SF-12v2, and known-groups validity. Responsiveness was measured with standardized effect sizes (SES).

Results

The mean administration time was approximately 2 min, and the ceiling effect of the EQ-5D-5L index was 13.6 %. The weighted kappa values and ICC of the EQ-5D-5L were 0.48–0.61 and 0.82, respectively. Similar dimensions of the EQ-5D-5L had higher correlations with those of WHOQoL-BREF and SF-12v2. As expected, elderly, female, low-educated, unemployed, higher number of comorbidities and medicines, patients’ perception of poor disease control, and having an adverse drug reaction tended to have poorer EQ-5D-5L scores. The SES of EQ-5D-5L index and EQ-VAS were considered small (0.33–0.42) for the improved group. For the worsened group, the SES of the EQ-5D-5L index were considered small (−0.29) but that of the EQ-VAS considered large (−0.82).

Conclusions

The EQ-5D-5L was practical, reliable, valid, and responsive in Thai patients with chronic diseases.
vorige artikel Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure
volgende artikel Differences in Patient Health Questionnaire and Aachen Depression Item Bank scores between tablet versus paper-and-pencil administration
Literatuur
1.
Brooks, R., & EuroQoL Group. (1996). EuroQoL: The current state of play. Health Policy, 37, 53–72.CrossRefPubMed
2.
Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22, 235–241.CrossRefPubMed
3.
Sakthong, P. (2008). Measurement of clinical-effect utility. Journal of Medical Association of Thailand, 91, S43–S52.
4.
Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2, 169–180.CrossRefPubMed
5.
Kaarlola, A., Pettila, V., & Kekki, P. (2004). Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Medicine, 30, 2245–2252.CrossRefPubMed
6.
Luo, N., Chew, L. H., Fong, K. Y., Koh, D. R., Ng, S. C., Yoon, K. H., et al. (2003). Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Quality of Life Research, 12, 87–92.CrossRefPubMed
7.
Marra, C. A., Woolcott, J. C., Kopec, J. A., Shojania, K., Offer, R., Brazier, J. E., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D0 and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571–1582.CrossRefPubMed
8.
Nowels, D., McGloin, J., Westfall, J. M., & Holcomb, S. (2005). Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Quality of Life Research, 14, 95–105.CrossRefPubMed
9.
Wu, A. W., Jacobson, D. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., et al. (2002). Validity and responsiveness of the EuroQOL as a measure of the health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11, 273–282.CrossRefPubMed
10.
Sakthong, P., Schommer, J. C., Gross, C. R., Prasithsirikul, W., & Sakulbumrungsil, R. (2009). Health utilities in patients with HIV/AIDS in Thailand. Value in Health, 12, 377–384.CrossRefPubMed
11.
Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727–1736.PubMedCentralCrossRefPubMed
12.
Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, S. M. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.CrossRefPubMed
13.
Hinz, A., Kohlmann, T., Stobel-Rochter, Y., Zenger, M., & Brahler, E. (2014). The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Quality of Life Research, 23, 443–447.CrossRefPubMed
14.
Kim, T. H., Kim, S. H., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21, 1065–1073.CrossRefPubMed
15.
Scalone, L., Coampichini, R., Fagiouli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D-3L with the new version EQ-5D-5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.CrossRefPubMed
16.
Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2014). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ-VAS in stroke patients. Quality of Life Research,. doi:10.​1007/​s11136-014-0873-7.
17.
Golicki, D., Niewada, M., Buczek, J., Karlinska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24, 845–850.PubMedCentralCrossRefPubMed
18.
Garcia-Gordillo, M. A., Pozo-Cruz, B. D., Adsuar, J. C., Sanchez-Martinez, F. I., & Abelian-Perpinan, J. M. (2014). Validation and comparison of the 15-D and EQ-5D-5L instruments in a Spanish Parkinson’s disease population sample. Quality of Life Research, 23, 1315–1326.CrossRefPubMed
19.
Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of life Outcomes, 10, 132.PubMedCentralCrossRefPubMed
20.
Agborsangaya, C. B., Lahtinen, M., Cooke, T., & Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of life Outcomes, 12, 74.PubMedCentralCrossRefPubMed
21.
Pattanaphesaj, J. (2014). Health related quality of life measure (EQ-5D-5L): Measurement property testing and its preference-based score in Thai population. Dissertation, Mahidol University, Bangkok.
22.
Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in Thai diabetes patients. Health and Quality of life Outcomes, 13, 14.PubMedCentralCrossRefPubMed
23.
WHOQOL Group. (1998). The World Health Organization Quality of Life assessment instrument (WHOQOL): Development and general psychometric properties. Social Science and Medicine, 46, 1569–1585.CrossRef
24.
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558.CrossRef
25.
Mahatnirunkul, S., Tuntipivatanakul, W., & Pumpisanchai, W. (1998). Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). Journal of Mental Health Thai, 5, 4–15.
26.
Nunnally, J. C, Jr. (1998). Psychometric theory (2nd ed.). New York: McGraw-Hill.
27.
Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: Quality Metric, Incorporated.
28.
Ware, J. E., Kosinski, M., Turner-Bowker, D., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metric, Incorporated.
29.
Rosner, B. (2000). Fundamental of Biostatistics (5th ed.). Pacific Grove, CA: Duxbury Thomson Learning.
30.
Fleiss, J. L., Levin, B., & Paik, M. C. (2013). Statistical methods for rates and proportions. New Jersey: Wiley.
31.
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., et al. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239–245.CrossRefPubMed
32.
Cohen, P. (1983). Applied multiple regression/correlation analysis for the behavioral sciences (2nd ed.). New Jersey: Lawrence Erlbaum Associates.
33.
Sakthong, P., Sakulbumrungsil, R., & Chabunthom, R. (2008). A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health and Quality of Life Outcomes, 6, 71.PubMedCentralCrossRefPubMed
34.
Sakthong, P., & Kasemsup, V. (2012). Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis. Value in Health, 15, S79–S84.CrossRefPubMed
35.
Saiguay, W., & Sakthong, P. (2013). The psychometric testing of the Thai version of the health utilities index in patients with ischemic heart disease. Quality of Life Research, 22, 1753–1759.CrossRefPubMed
36.
Maindal, H. T., Sokolowski, I., & Vedsted, P. (2009). Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health, 9, 209.PubMedCentralCrossRefPubMed
Metagegevens
Titel
Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases
Auteurs
Phantipa Sakthong
Nontapat Sonsa-ardjit
Pattarin Sukarnjanaset
Wipaporn Munpan
Publicatiedatum
06-06-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 12/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1038-z

Andere artikelen Uitgave 12/2015

Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population

Steven P. Reise and Dennis A. Revicki: Handbook of item response theory modeling: applications to typical performance assessment. Multivariate applications series

  • Book Review

Clinical improvement and satisfaction after total joint replacement: a prospective 12-month evaluation on the patients’ perspective

Proposing a re-adapted successful aging model addressing chronic diseases in low- and middle-income countries

  • Brief Communication

Population-level impact of loss on survivor mortality risk

  • Open Access
  • Brief Communication

The experience of cancer survivors in community-based psycho-social support activities in Shanghai, China: a qualitative study